The General Pharmaceutical Council (GPhC) has raised concerns over a 7% increase in the number of fitness-to-practise (FtP) complaints brought to the regulator between July 2019 and September 2019. In its November 2019 council papers, the GPhC said it had received 709 FtP concerns between July 2019 and September 2019, compared with 662 concerns received between March 2019 and June 2019.
展开▼